#Emboline
LightNews LightNews
newsen.bsky.social
Emboline Launches Revolutionary Embolic Protection System in the U.S. Market#USA#Santa_Cruz#Medical_Device#Emboline#Emboliner
Emboline Launches Revolutionary Embolic Protection System in the U.S. Market
Emboline, Inc. has successfully introduced its innovative Emboliner® Embolic Protection System for commercial use in the U.S., marking a significant milestone in medical technology.
third-news.com
October 2, 2026 at 12:04 PM
newsen.bsky.social
Emboline's Emboliner® System Achieves First U.S. Commercial Use, Transcatheter Procedures Begin#USA#FDA#Santa_Cruz#Emboline#Emboliner
Emboline's Emboliner® System Achieves First U.S. Commercial Use, Transcatheter Procedures Begin
Emboline, Inc. marks a significant milestone as its Emboliner® Embolic Protection System secures its first use in the U.S., enhancing patient safety during heart procedures.
third-news.com
October 2, 2026 at 12:10 PM
newsen.bsky.social
Emboline Gets FDA 510(k) Approval for Innovative Embolic Protection Device#USA#Santa_Cruz#FDA_Clearance#Emboline#Emboliner
Emboline Gets FDA 510(k) Approval for Innovative Embolic Protection Device
Emboline, Inc. has received FDA 510(k) clearance for its Emboliner® system, enhancing patient safety during heart procedures by capturing embolic debris.
third-news.com
September 9, 2026 at 12:36 PM
ip-law.bsky.social
For Medical Devices, “Possible Use” Amounts To Infringement Only If The Use Is In Line With Medical Practice
For Medical Devices, “Possible Use” Amounts To Infringement Only If The Use Is In Line With Medical Practice
Emboline v. AorticLab—UPC_CFI_628/2024, judgment of January 13, 2026 - The UPC Munich Local Division (the LD Munich) has dismissed an...
www.jdsupra.com
March 24, 2026 at 5:32 PM
dsmyth.bsky.social
So, it turns out that no, you can't sue someone at the UPC and then demand security for your legal costs for them to have the privilege of defending themselves. Only a defendant can seek security for costs. The UPC Court of Appeal ends some first instance madness.
eip.com/uk/latest/ar...
UPC Court of Appeal Clarifies Limits on Security for Costs in Emboline v. AorticLab
In a significant ruling before the Unified Patent Court (UPC)[1], the Court of Appeal has clarified that a claimant in an infringement action cannot request security for costs from a defendant who fil...
eip.com
July 23, 2025 at 4:01 PM
frank-jdsupra.bsky.social
For Medical Devices, “Possible Use” Amounts To Infringement Only If The Use Is In Line With Medical Practice
For Medical Devices, “Possible Use” Amounts To Infringement Only If The Use Is In Line With Medical Practice
Emboline v. AorticLab—UPC_CFI_628/2024, judgment of January 13, 2026 - The UPC Munich Local Division (the LD Munich) has dismissed an...
www.jdsupra.com
March 24, 2026 at 5:32 PM
health-law-news.bsky.social
For Medical Devices, “Possible Use” Amounts To Infringement Only If The Use Is In Line With Medical Practice
For Medical Devices, “Possible Use” Amounts To Infringement Only If The Use Is In Line With Medical Practice
Emboline v. AorticLab—UPC_CFI_628/2024, judgment of January 13, 2026 - The UPC Munich Local Division (the LD Munich) has dismissed an...
www.jdsupra.com
March 24, 2026 at 5:32 PM
paulaindie.bsky.social
Lo de antico es lo que me
dio curiosidad, pero me emboliné y no he trabajado en eso. Mañana será
February 16, 2025 at 12:52 AM
longtail-news.bsky.social
Feed: "FinSMEs"
Published on Wednesday, March 11, 2026
Emboline Raises $20M in Growth Capital from Trinity Capital
Emboline, Inc., a Santa Cruz, CA-based privately held medical technology company, raised $20M in Growth Capital
www.finsmes.com
March 11, 2026 at 4:55 PM
patesalo-e.bsky.social
AorticLab S.r.l. Announces Clear Victory Before the European Unified Patent Court in Litigation Brought by Emboline, Inc. - PR Newswire: AorticLab S.r.l. Announces Clear Victory Before the European Unified Patent Court in Litigation Brought by Emboline, Inc.  PR Newswire
AorticLab S.r.l. Announces Clear Victory Before the European Unified Patent Court in Litigation Brought by Emboline, Inc. - PR Newswire
AorticLab S.r.l. Announces Clear Victory Before the European Unified Patent Court in Litigation Brought by Emboline, Inc.  PR Newswire
www.prnewswire.com
January 20, 2026 at 11:07 AM
patesalo-e.bsky.social
AorticLab fends off infringement suit by US competitor Emboline - JUVE Patent: AorticLab fends off infringement suit by US competitor Emboline  JUVE Patent
AorticLab fends off infringement suit by US competitor Emboline - JUVE Patent
AorticLab fends off infringement suit by US competitor Emboline  JUVE Patent
www.juve-patent.com
January 16, 2026 at 2:44 PM
patesalo-e.bsky.social
Emboline launches patent… https://news.google....
October 29, 2024 at 3:42 PM
blueresearch.bsky.social
Emboline closes $20M in growth capital from Trinity Capital
Reported Wednesday, Mar 11 - 8:05am EDT (TheFly subscription required to read more.)
thefly.com
March 11, 2026 at 12:11 PM
newsen.bsky.social
Emboline Wins Key Legal Battle Against AorticLab Over Patent Rights in Germany#Germany#Munich#Patent_Rights#AorticLab#Emboline
Emboline Wins Key Legal Battle Against AorticLab Over Patent Rights in Germany
A recent court ruling in Germany favored Emboline, Inc. against AorticLab, reinforcing the significance of intellectual property in medical technology advancements.
third-news.com
July 15, 2026 at 12:16 PM
newsen.bsky.social
Emboline's Game-Changing PROTECT H2H Trial Results Herald New Era in TAVR Embolic Protection#USA#TAVR#Santa_Cruz#Emboliner#ACC_2026
Emboline's Game-Changing PROTECT H2H Trial Results Herald New Era in TAVR Embolic Protection
Emboline, Inc. has unveiled groundbreaking results from its PROTECT H2H trial, showcasing the Emboliner® system's potential in TAVR procedures. This innovative approach promises to redefine embolic protection standards in cardiac interventions.
third-news.com
March 30, 2026 at 12:08 PM
newsen.bsky.social
Emboline, Inc. Closes $20 Million Funding to Enhance Embolic Protection System Innovation#USA#Santa_Cruz#Trinity_Capital#Emboline#Emboliner
Emboline, Inc. Closes $20 Million Funding to Enhance Embolic Protection System Innovation
Emboline, Inc. has secured $20 million from Trinity Capital to advance the commercialization of its Emboliner® system, which aims to reduce stroke risk during heart procedures.
third-news.com
March 11, 2026 at 12:35 PM
newsen.bsky.social
Trinity Capital Invests $20 Million in Emboline to Enhance Heart Procedure Technologies#United_States#Phoenix#Trinity_Capital#Emboline#Heart_Procedure
Trinity Capital Invests $20 Million in Emboline to Enhance Heart Procedure Technologies
Trinity Capital has committed $20 million to Emboline, aiming to boost the safety of heart procedures with innovative technology designed to reduce complications.
third-news.com
March 11, 2026 at 12:32 PM
newsen.bsky.social
Emboline, Inc. Secures $20 Million for Product Launch of the Emboliner® System in Stroke Prevention#USA#Santa_Cruz#Trinity_Capital#Emboline#Emboliner
Emboline, Inc. Secures $20 Million for Product Launch of the Emboliner® System in Stroke Prevention
Emboline, Inc. announces successful acquisition of $20 million in funding from Trinity Capital to support the launch of the Emboliner® Embolic Protection System aimed at minimizing stroke risk during TAVR procedures.
third-news.com
March 11, 2026 at 12:20 PM
newsen.bsky.social
AorticLab Triumphs Over Emboline in UPC Patent Litigation, Securing Patient Access#Italy#AorticLab#Emboline#FLOWer™#Colleretto_Giacosa
AorticLab Triumphs Over Emboline in UPC Patent Litigation, Securing Patient Access
AorticLab S.r.l. achieves a crucial win at the Unified Patent Court, ensuring patients can access its innovative FLOWer™ embolic protection device without infringement concerns.
third-news.com
January 20, 2026 at 11:05 AM
newsen.bsky.social
Emboline, Inc. Marks Milestone in Embolic Protection with Completion of Trial Enrollment for Innovative Catheter#USA#TAVR#Santa_Cruz#Emboline#Emboliner
Emboline, Inc. Marks Milestone in Embolic Protection with Completion of Trial Enrollment for Innovative Catheter
Emboline, Inc. has successfully finished patient enrollment for its pivotal clinical trial focusing on the Emboliner® Embolic Protection Catheter, aimed at ensuring patient safety during TAVR procedures.
third-news.com
October 23, 2025 at 12:43 PM
newsen.bsky.social
Emboline, Inc. Finalizes Patient Enrollment for Pivotal IDE Trial of Emboliner Catheter Designed for TAVR Procedures#USA#TAVR#Santa_Cruz#Emboline#Emboliner
Emboline, Inc. Finalizes Patient Enrollment for Pivotal IDE Trial of Emboliner Catheter Designed for TAVR Procedures
Emboline, Inc. has completed patient enrollment in a key IDE trial for their Emboliner® device, aimed at protecting patients during TAVR procedures. This milestone represents a significant step toward enhanced patient safety.
third-news.com
October 23, 2025 at 12:22 PM
stocktitan.net
#TRIN Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology

https://www.stocktitan.net/news/TRIN/trinity-capital-inc-provides-20-million-in-growth-capital-to-j2mhg3ec1ab5.html
Trinity's $20M bet on device to cut stroke risk in heart procedures
Catheter designed to capture debris during minimally invasive heart procedures gets $20M from Trinity Capital to fund Emboliner's launch and approvals push.
www.stocktitan.net
March 11, 2026 at 12:00 PM
drbigmac.bsky.social
First Emboline Cerebral Protection Device case with South Denver Cardiology at Littleton hospital. Lowering risks during TAVR still an important goal!! #Medbluesky #Interventionalcarciology
#Cardiology
March 19, 2025 at 4:12 PM